Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression

被引:37
作者
Choge, Isaac
Cilliers, Tonie
Walker, Polly
Taylor, Natasha
Phoswa, Mary
Meyers, Tammy
Viljoen, Johannes
Violari, Avy
Gray, Glenda
Moore, Penny L.
Papathanosopoulos, Maria
Morris, Lynn
机构
[1] Natl Inst Communicable Dis, AIDS Virus Res Unit, ZA-2131 Johannesburg, South Africa
[2] Univ Oxford, Dept Zool, Oxford OX1 3PS, England
[3] Chris Hani Baragwanath Hosp, Johannesburg, South Africa
[4] Univ Free State, Dept Virol, Bloemfontein, South Africa
关键词
D O I
10.1089/aid.2006.22.458
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The genotypes and biological phenotypes of HIV-1 isolates obtained from 40 perinatally infected children in South Africa were analyzed. This included 15 infants who had HIV-related symptoms, most of whom died within 2 years of birth (rapid progressors), and 25 children who survived between 4 and 9 years with varying signs of disease (slow progressors). Heteroduplex mobility assays and sequence analysis confirmed that within the env and gag regions, all isolates were HIV-1 subtype C. Viral isolates from 14 of the 15 rapid progressors used the CCR5 coreceptor, whereas 1 (02ZARP1) used both the CXCR4 and CCR5 coreceptors. Among the 25 slow progressors, 22 isolates used CCR5 only, 2 used CXCR4 only, and 1 used both CCR5 and CXCR4. Two of the slow-progressing children who harbored CXCR4- using viruses had AIDS. All four CXCR4- using viruses had genotypic changes in the V3 region previously shown to be associated with CXCR4 usage. This cross-sectional study shows that HIV-1 subtype C viruses from both rapid- and slow-progressing perinatally infected children used predominantly CCR5. Similar to adults, CXCR4 usage was uncommon among HIV-1 subtype C isolates from pediatric infections.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 29 条
[21]  
Saba J, 2002, LANCET, V359, P1178
[22]   Paediatric HIV infection [J].
Scarlatti, G .
LANCET, 1996, 348 (9031) :863-868
[23]   In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression [J].
Scarlatti, G ;
Tresoldi, E ;
Bjorndal, A ;
Fredriksson, R ;
Colognesi, C ;
Deng, HK ;
Malnati, MS ;
Plebani, A ;
Siccardi, AG ;
Littman, DR ;
Fenyo, EM ;
Lusso, P .
NATURE MEDICINE, 1997, 3 (11) :1259-1265
[24]   TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) FROM MOTHER-TO-CHILD CORRELATES WITH VIRAL PHENOTYPE [J].
SCARLATTI, G ;
HODARA, V ;
ROSSI, P ;
MUGGIASCA, L ;
BUCCERI, A ;
ALBERT, J ;
FENYO, EM .
VIROLOGY, 1993, 197 (02) :624-629
[25]   Viral load and disease progression in infants infected with human immunodeficiency virus type 1 [J].
Shearer, WT ;
Quinn, TC ;
LaRussa, P ;
Lew, JF ;
Mofenson, L ;
Almy, S ;
Rich, K ;
Handelsman, E ;
Diaz, C ;
Pagano, M ;
Smeriglio, V ;
Kalish, LA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (19) :1337-1342
[26]   CLINICAL-SIGNIFICANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN INFECTED CHILDREN [J].
SPENCER, LT ;
OGINO, MT ;
DANKNER, WM ;
SPECTOR, SA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03) :491-495
[27]   PROGNOSTIC FACTORS AND SURVIVAL IN CHILDREN WITH PERINATAL HIV-1 INFECTION [J].
TOVO, PA ;
DEMARTINO, M ;
GABIANO, C ;
CAPPELLO, N ;
DELIA, R ;
LOY, A ;
PLEBANI, A ;
ZUCCOTTI, GV ;
DALLACASA, P ;
FERRARIS, G ;
CASELLI, D ;
FUNDARO, C ;
DARGENIO, P ;
GALLI, L ;
PRINCIPI, N ;
STEGAGNO, M ;
RUGA, E ;
PALOMBA, E .
LANCET, 1992, 339 (8804) :1249-1253
[28]   Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140 [J].
Trkola, A ;
Ketas, TJ ;
Nagashima, KA ;
Zhao, L ;
Cilliers, T ;
Morris, L ;
Moore, JP ;
Maddon, PJ ;
Olson, WC .
JOURNAL OF VIROLOGY, 2001, 75 (02) :579-588
[29]   SELECTIVE TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS FROM MOTHERS TO INFANTS [J].
WOLINSKY, SM ;
WIKE, CM ;
KORBER, BTM ;
HUTTO, C ;
PARKS, WP ;
ROSENBLUM, LL ;
KUNSTMAN, KJ ;
FURTADO, MR ;
MUNOZ, JL .
SCIENCE, 1992, 255 (5048) :1134-1137